Correlation Between Cigna Corp and Vivos Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cigna Corp and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cigna Corp and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cigna Corp and Vivos Therapeutics, you can compare the effects of market volatilities on Cigna Corp and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cigna Corp with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cigna Corp and Vivos Therapeutics.

Diversification Opportunities for Cigna Corp and Vivos Therapeutics

-0.68

Correlation Coefficient

Cigna Corp  Vivos Therapeutics

Excellent diversification

The 3 months correlation between Cigna and Vivos is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Cigna Corp and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and Cigna Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cigna Corp are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of Cigna Corp i.e., Cigna Corp and Vivos Therapeutics go up and down completely randomly.

Pair Corralation between Cigna Corp and Vivos Therapeutics

Allowing for the 90-day total investment horizon Cigna Corp is expected to under-perform the Vivos Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cigna Corp is 2.21 times less risky than Vivos Therapeutics. The stock trades about -0.13 of its potential returns per unit of risk. The Vivos Therapeutics is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest  264.00  in Vivos Therapeutics on September 23, 2024 and sell it today you would earn a total of  234.00  from holding Vivos Therapeutics or generate 88.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cigna Corp  vs.  Vivos Therapeutics

Cigna Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cigna Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Vivos Therapeutics

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cigna Corp and Vivos Therapeutics

The main advantage of trading using opposite Cigna Corp and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cigna Corp position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.

The idea behind Cigna Corp and Vivos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.